Seeking Alpha · 1 min read

Halozyme projects 2026 non-GAAP EPS of $8.65-$9.00 while raising revenue outlook to $1.835B-$1.91B

Halozyme projects 2026 non-GAAP EPS of $8.65-$9.00 while raising revenue outlook to $1.835B-$1.91B

This is a summary aggregated from Seeking Alpha. Read the complete article on the original site:

Read full article at Seeking Alpha

Related stories